The Patent Finder

Terms ending in 2027

Ucb Pharma S.A.

Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,604,051Thieno-Pyridine Derivatives as Mek Inhibitors
In force
 · Medium confidence
Ucb Pharma S.A.In forceMedium confidence
US D676,552Needle Cap for a Medication Administration Device
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,309,215Chiral Intermediate, Process for Producing the Same and Its Use in the Manufacture of Tolterodine, Fesoterodine, or the Active Metabolite Thereof
In force
 · Low confidence
Ucb Pharma GmbHIn forceLow confidence
US 7,807,715Pharmaceutical Compositions Comprising Fesoterodine
In force
 · High confidence
Ucb Pharma GmbHIn forceHigh confidence
US 9,364,541Pharmaceutical Compositions Comprising Fesoterodine
In force
 · Medium confidence
Ucb Pharma GmbHIn forceMedium confidence
US 9,095,557Anticonvulsant Combination Therapy
In force
 · Medium confidence
Ucb Pharma GmbHIn forceMedium confidence
US 9,446,011Anticonvulsant Combination Therapy
In force
 · High confidence
Ucb Pharma GmbHIn forceHigh confidence
US 7,888,344Fused Thiazole Derivatives as Kinase Inhibitors
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 7,982,058Chiral Intermediate, Process for Producing the Same and Its Use in the Manufacture of Tolterodine, Fesoterodine, or the Active Metabolite Thereof
In force
 · High confidence
Ucb Pharma GmbHIn forceHigh confidence
US 8,633,194Pharmaceutical Composition Of Piperazine Derivatives
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
5 more term ends in 2027 · Pro
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15, all of them expiring within the 18 months from Nov 21, 2026.
Upgrade to Pro
9 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited